Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
  1. Home
  2. Search

Refine search

Refine search

Access:
Content type:
Publication date:
Apply   From and To filters
Subject: Show more
Journals Show more
Publishers: Show more
Societies Show more
Series: Show more
Collections: Show more

Actions for selected content:

Select all | Deselect all
  • View selected items
  • Export citations
  • Download PDF (zip)
  • Save to Kindle
  • Save to Dropbox
  • Save to Google Drive

Save Search

You can save your searches here and later view and run them again in "My saved searches".

Please provide a title, maximum of 40 characters.
Cancel
×

2 results

  • Chapter 6 - Neuroimaging and Staging

  • from Section 2 - Progress with Clinical Staging
  • Edited by Patrick D. McGorry, University of Melbourne, Ian B. Hickie, University of Sydney
  • Book:
    Clinical Staging in Psychiatry
    Published online:
    08 August 2019
    Print publication:
    29 August 2019, pp 103-139

  • Summary

    Integration of brain structural information into prognostic and treatment formulation is key for achieving an all-encompassing biopsychosocial approach in psychiatry. Uncovering biological markers of specific mental illnesses, specific illness stages and of remission, may help further our understanding of the aetiology and precipitators of certain types of psychopathologies, identify central neurobiological processes as distinct from epiphenomena, validate boundaries of clinical groups, and potentially aid in predicting response to treatment. This book chapter reviewed the current structural neuroimaging evidence in three prominent mental illness domains: schizophrenia-spectrum, bipolar and depressive disorders. The large degree of overlap in abnormal neuropathology across the broad mental illness groups, which is no doubt partially due to within-group heterogeneity, makes the discovery of sets or networks of localized diagnosis-specific neural biomarkers unlikely. However, this is not to say that subtle distinctions in neural abnormalities do not exist, but rather challenges the usefulness of traditional diagnostic categories in the context of brain imaging being applied within a clinical staging model. A focus on identifying and characterising microscale circuits that are dysfunctional and which map onto symptomatology in a transdiagnostic manner, may have the greatest implications for clinical translation in the near future.

  • Hippocampal subfields and visuospatial associative memory across stages of schizophrenia-spectrum disorder

  • Cassandra M. J. Wannan, Vanessa L. Cropley, M. Mallar Chakravarty, Tamsyn E. Van Rheenen, Sam Mancuso, Chad Bousman, Ian Everall, Patrick D. McGorry, Christos Pantelis, Cali F. Bartholomeusz
  • Journal:
    Psychological Medicine / Volume 49 / Issue 14 / October 2019
    Published online by Cambridge University Press:
    04 December 2018, pp. 2452-2462
    Print publication:
    October 2019
  • Background

    While previous studies have identified relationships between hippocampal volumes and memory performance in schizophrenia, these relationships are not apparent in healthy individuals. Further, few studies have examined the role of hippocampal subfields in illness-related memory deficits, and no study has examined potential differences across varying illness stages. The current study aimed to investigate whether individuals with early and established psychosis exhibited differential relationships between visuospatial associative memory and hippocampal subfield volumes.

    Methods

    Measurements of visuospatial associative memory performance and grey matter volume were obtained from 52 individuals with a chronic schizophrenia-spectrum disorder, 28 youth with recent-onset psychosis, 52 older healthy controls, and 28 younger healthy controls.

    Results

    Both chronic and recent-onset patients had impaired visuospatial associative memory performance, however, only chronic patients showed hippocampal subfield volume loss. Both chronic and recent-onset patients demonstrated relationships between visuospatial associative memory performance and hippocampal subfield volumes in the CA4/dentate gyrus and the stratum that were not observed in older healthy controls. There were no group by volume interactions when chronic and recent-onset patients were compared.

    Conclusions

    The current study extends the findings of previous studies by identifying particular hippocampal subfields, including the hippocampal stratum layers and the dentate gyrus, that appear to be related to visuospatial associative memory ability in individuals with both chronic and first-episode psychosis.